Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suxiao Jiuxin Pill for Vulnerable Plaque in STEMI
NCT05466968Phase 4Not yet recruiting
- Start
- Aug 2022
- Primary completion
- Jun 2025
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Suxiao Jiuxin Pills in ST elevation myocardial infarction (STEMI). Planned start Aug 2022; status: not yet recruiting.
02
Drugs
Suxiao Jiuxin Pills
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05466968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466968.